Reverse Phase HPLC (RP-HPLC)

Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) is a chromatographic technique that separates molecules based on their hydrophobicity. It is called "reverse phase" because the stationary phase is nonpolar (hydrophobic) and the mobile phase is polar,  the opposite of normal phase chromatography. Molecules with greater hydrophobicity interact more strongly with the column and elute later. Separation is achieved by running a gradient from a high-aqueous to high-organic mobile phase, progressively eluting retained species. It is a high-resolution method in CMC for assessing product identity, purity, and for quantifying product-related variants.

• Legacy Techniques: Early liquid chromatography on wide-bore columns with large particles, offering low efficiency and long run times.
• Established Standard: RP-HPLC and RP-UPLC using columns packed with silica particles that are chemically modified with hydrophobic ligands (e.g., C4, C8, C18). UPLC (Ultra-High-Performance) systems use sub-2-micron particles for faster, higher-resolution separations.
• Alternatives: Routine evolution has been the coupling of RP-HPLC directly to high-resolution mass spectrometry (LC-MS), now a standard approach for peptide mapping and Multi-Attribute Methods (MAM).

For mRNA: Standard RP-HPLC (without ion-pairing) can be used to quantify total nucleic acid mass using UV detection at 260 nm. Under conventional RP conditions, intact mRNA, fragments, and free nucleotides typically do not retain meaningfully on the hydrophobic stationary phase and elute near the void volume, allowing quantification based on peak area.

Advantage over SoloVPE / Direct A260 Spectroscopy:

For Drug Substance (DS): RP-HPLC may provide improved robustness when analyzing process intermediates or less-purified material by separating nucleic acids from hydrophobic process-related impurities, excipients, or aggregates that could distort baseline absorbance or contribute to measurement variability in direct spectroscopic methods. In well-purified DS, however, the analytical advantage over validated A260/SoloVPE methods is often limited.

For Drug Product (DP): In mRNA–LNP formulations, the organic mobile phase disrupts the nanoparticle structure upon injection. Lipid components dissolve and are retained on the RP column, while released RNA elutes early. This can reduce turbidity and light-scattering artifacts that may bias direct UV-based measurements, providing a cleaner UV signal for quantification.

Method Comparison: RP-HPLC vs HIC vs IEX

RP-HPLC: Reverse Phase Chromatography

A high-resolution method for hydrophobicity-based separations

• Stationary Phase: Nonpolar (C4, C8, or C18 silica).

• Mobile Phase: Aqueous/Organic gradient (typically Water/Acetonitrile) with acidic modifiers (TFA, Formic Acid).

• Separation Basis: Hydrophobicity. Molecules interact with the nonpolar "tails" of the column; elution is achieved by increasing organic solvent concentration.

• Typical Use Cases: * Peptide Mapping: High-resolution separation of digested fragments.

  • LNP Analysis: Quantification of individual lipid components (using CAD/ELSD).

  • ADCs and conjugates: Analysis of free drug, linker-related impurities, and in some workflows drug-load related species.
    Proteins and peptides: Separation of hydrophobic variants and peptide mapping fragments

• CMC Note: Conditions are denaturing. Do not use RP-HPLC if you need to recover the protein in its native, active state.

HIC: Hydrophobic Interaction Chromatography

The "Gentle" Hydrophobic Assay.

• Stationary Phase: Weakly hydrophobic (Phenyl, Butyl, or Ether ligands).

• Mobile Phase: "Salt-out" gradient. High salt (e.g., Ammonium Sulfate) promotes binding; decreasing salt promotes elution.

• Separation Basis: Surface Hydrophobicity. Similar to RP-HPLC but performed under aqueous, non-denaturing conditions.

Typical Use Cases:

• ADCs: Native DAR species separation
• Proteins: Hydrophobic variants under non-denaturing conditions
• Orthogonal characterization when native-like conditions are preferred

• CMC Note: HIC is the preferred "orthogonal" method to RP-HPLC when protein folding and activity must be maintained.

Ion-Exchange Chromatography

Defining the Charge Profile.

• Stationary Phase: Charged functional groups (Anion exchange = +, Cation exchange = -).

• Mobile Phase: Aqueous salt gradient (NaCl) or pH gradient.

• Separation Basis: Net Surface Charge. Molecules elute based on their isoelectric point and the buffer pH.

• Typical Use Cases:

  • Charge Variants: Quantifying acidic and basic variants (Deamidation, C-terminal Lysine clipping).

  • mRNA Integrity: Separating full-length mRNA from shorter, truncated impurities (using AEX).

  • AAV Capsids: In some workflows, anion exchange methods (AEX) can help separate capsid populations with different charge characteristics, including empty and genome-containing species.

• Output: A chromatogram plotting detector response (typically UV absorbance) versus retention time.
• Analysis: The software integrates the area of the main peak and all impurity peaks. The relative percentage of each is calculated.
• Interpretation: The retention time of the main peak serves as an indicator of identity, while the purity is reported as the percent main peak area. For Antibody-Drug Conjugates, regulatory agencies require the control of key CQAs like the average drug-to-antibody ratio (DAR) and the amount of free drug. For ADCs, hydrophobic chromatography methods such as HIC and, in some workflows, RP-based methods can support control of attributes such as drug-load distribution and free drug-related impurities

• High Resolution: Provides excellent separation of molecules with very subtle differences in hydrophobicity.
• Robust & Reproducible: A mature and reliable technology that can be readily validated for use in QC labs.
• Quantitative: Offers high precision and accuracy for quantifying the relative levels of different variants.
• Versatile: Can be used for a wide range of molecules, from small drug linkers to large proteins.

• Denaturing Conditions: The use of organic solvents and acidic conditions typically denatures proteins, which is acceptable for primary structure or impurity analysis but unsuitable for assessing native conformation or activity.
• Potential for On-Column Artifacts: Proteins can sometimes adsorb irreversibly to the column, leading to poor recovery.
• Complex Method Development: Optimizing the column chemistry, mobile phases, and gradient to achieve a good separation can be challenging.

• Resolution: A system suitability criterion is always set for the minimum resolution between the main peak and a key variant or impurity.
• Specificity: Demonstrating that the method can resolve the main peak from known impurities, often using artificially stressed samples.
• Precision: Demonstrating low variability in both retention times and reported percent peak areas.
• Accuracy & Linearity: Assessed by analyzing samples of known concentrations and purity to demonstrate the method's accuracy and linear response.

RP-HPLC methods must be rigorously standardized to ensure reproducibility across laboratories and manufacturing sites. System suitability is commonly supported by qualified in-house standards, reference lots, or fit-for-purpose control samples. For peptide mapping and related workflows, reference peptides or system suitability mixtures may be used where appropriate. For biologics, this often includes stressed or spiked samples to confirm separation of oxidized, deamidated, or clipped variants. In the case of antibody–drug conjugates (ADCs), reference lots with a defined drug-to-antibody ratio (DAR) and free drug content are used to set calibration and monitor assay accuracy. Retention times are typically normalized using internal standards or peptide reference markers, and column performance is tracked over time to detect drift. 

• mRNA / LNP:

  Lipid Quantification: Separation and quantification of the 4 LNP lipid components (Ionizable lipid, Cholesterol, Helper lipid, PEG-lipid) using CAD or ELSD detection. UV detection is not suitable as most lipids lack chromophores.

  mRNA Concentration: Quantification of total nucleic acid mass using UV detection at 260 nm 

  Note: This approach measures total nucleic acid mass (intact mRNA + truncated species + small RNA fragments + free nucleotides). To resolve RNA species, assess integrity, or characterize structural attributes (e.g., purity, capping, poly(A) tail), Ion-Pair RP-HPLC (IP-RP-HPLC) or orthogonal techniques such as CE are required.

Standard RP vs. Ion-Pair RP for mRNA–LNPs

• Standard RP: Used for LNP Lipid Identity and Ratio (Ionizable, Helper, Cholesterol, PEG).

• Ion-Pair RP (IP-RP): Uses agents like TEAA or HFIP to allow the negatively charged mRNA to interact with the hydrophobic column. (Ion-pair RP methods are often used when retention and separation of RNA species are needed, including selected workflows for RNA purity assessment and for specialized characterization such as poly(A) tail analysis. Other orthogonal methods may also be used depending on the attribute of interest.)

• ADCs & Conjugates: A critical method used to quantify free cytotoxic drug impurities and drug-load distribution.

• mAbs & Proteins: RP-based methods are widely used in protein characterization and may be used to monitor hydrophobic product-related variants or oxidation-related changes, especially in peptide mapping and other denaturing workflows.